HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Keenan, A. M. Articles by Larson, S. M. Search for Related Content PubMed PubMed Citation Articles by Keenan, A. M. Articles by Larson, S. M.

Monoclonal Antibodies in Nuclear Medicine

Department of Nuclear Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland; and Division of Nuclear Medicine, Georgetown University Hospital, Washington, DC

Correspondence: For reprints contact: Andrew M. Keenan, MD, Dept. of Nuclear Medicine, Building 10, Rm. 1C401, National Institutes of Health, Bestheda, MD 20205.

ABSTRACT

Monoclonal antibodies have been a part of biomedical research for nearly a decade, yet a comparable period of time may be required before radiolabeled monoclonal antibodies come into standard practice in the diagnosis and therapy of human disease. Difficulties in identifying appropriate antigens, developing the optimal antibody species, attaching the most effective radiolabel and choosing the best method of administration all confound present investigations. The problems confronting therapeutic applications are, for the most part, an extension of those associated with diagnostic techniques. Still, there is much well-deserved optimism, and progress in all areas of investigation will ultimately come together to resolve most if not all of these problems. It is inevitable that monoclonal antibodies will have significant impact on the practice of nuclear medicine, and presented here is a review of the basic knowledge as well as an update on the current status of radiolabeled monoclonal antibodies in medicine.

This article has been cited by other articles:

				G. H. Hinkle, R. W. Beightol, N. Gregorio, and S. R. Lefevre Pharmacy Considerations Related to Radiolabeled Monoclonal Antibodies Journal of Pharmacy Practice, January 1, 1989; 2(3): 177 - 184. [Abstract] [PDF]